Tag Archives: U.S.

Pfizer’s keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Think you’re busy? Take a look at Pfizer’s commercial team for oncology, which is currently launching four new drugs, three new indications for older drugs, and a biosimilar. And that’s just in the U.S. It’s taken some serious internal organizing on Pfizer’s part, but so far managing the multiple rollouts has been “done very well,”… Read More »

8-year-old African child who was flown to the U.S. for surgery by NBA star Dikembe Mutombo has died

(Photo by Marcus Ingram/Getty Images for UNICEF) Former NBA star Dikembe Mutombo is mourning the death of the 8-year-old African boy that he flew to the United States earlier this month for surgery to remove a tumor. The child, Matadi Sela Petit of Kinshasa, Congo, died after suffering a “rare and unpredictable genetic reaction to… Read More »

Most U.S. patients not using online medical portals

(Reuters Health) – Most people in the U.S. with health insurance don’t use the patient portals that are increasingly provided by doctors for online communication, a new study suggests. In a nationally representative survey, researchers found that nearly two-thirds of insured participants had not used an online medical portal in the past year. Disparities among… Read More »

U.S. FDA approves Alexion Pharma's blood disorder drug

(Reuters) – The U.S. Food and Drug Administration has approved Alexion Pharmaceuticals Inc’s blood disorder drug Ultomiris, the pharma regulator’s website showed on Friday. The drug aims to treat paroxysmal nocturnal hemoglobinuria (PNH), a rare, acquired, life-threatening disorder in which red blood cells divide prematurely. Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila… Read More »

Spiration Valve for Severe Emphysema Approved in U.S.

December 10th, 2018 Editors Medicine, Thoracic Surgery Olympus landed FDA approval for its Spiration Valve System, a product designed to treat people suffering from severe emphysema. It’s used to perform bronchoscopic lung volume reduction (BLVR) procedures, which channel air away from hyperinflated portions of the lungs to healthier areas. In many patients this results in easier… Read More »

CanGaroo Envelope Now Cleared in U.S. to Protect Implantable Neurostimulators

Aziyo Biologics, out of Silver Springs, Maryland, won FDA clearance for its CanGaroo Envelope to be used with implantable neurostimulators. It has previously been cleared only for encapsulating implantable cardiac devices such as pacemakers and defibrillators. The CanGaroo Envelope is, contrary to what its name may imply, is a porcine extracellular matrix, essentially pig’s tissue with… Read More »